Thomas S. Winokur

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.

Lalage M. Wakefield, Thomas S. Winokur, Robin S. Hollands et al. · Journal of Clinical Investigation · 1990 · 316 citations · Full text

Plasma Half-life, Developmental Biology, Growth Hormone +12

Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer

Robert J. Cerfolio, Ayesha S. Bryant, Thomas S. Winokur et al. · The Annals of Thoracic Surgery · 2004 · 196 citations

Oncologic Imaging, Neoadjuvant Therapy, Medicine +7

Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1.

Anita B. Roberts, N S Roche, Thomas S. Winokur et al. · Journal of Clinical Investigation · 1992 · 101 citations · Full text

Cardiac Muscle, Immunology, Endogenous Tgf-beta +21

Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.

Evan C. Unger, Thomas S. Winokur, Peter MacDougall et al. · Radiology · 1989 · 90 citations

Engineering, Oncologic Imaging, Imaging Agent +16

Expression of transforming growth factor-βs 1–4 in chicken embryo chondrocytes and myocytes

Sonia B. Jakowlew, Pamela J. Dillard, Thomas S. Winokur et al. · Developmental Biology · 1991 · 86 citations

Developmental Biology, Growth Factor-βs 1–4, Cell Proliferation +7